Optival Health Solutions, a subsidiary of Medplus, received suspension orders for drug licenses at four locations on April 2, 2025, leading to a potential revenue loss of approximately Rs 2.87 lakhs in total.
AI Assistant
Medplus Health Services Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.